Journal article
Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
Metabolites, Vol.12(5), p.469
05/23/2022
DOI: 10.3390/metabo12050469
PMCID: PMC9145280
PMID: 35629973
Abstract
Several cancers, including breast cancers, show dependence on glutamine metabolism. The purpose of the present study was to determine the mechanistic basis and impact of differential glutamine metabolism in nonmetastatic and metastatic murine mammary cancer cells. Universally labeled
C
-glutamine metabolic tracing, qRT-PCR, measures of reductive-oxidative balance, and exogenous ammonium chloride treatment were used to assess glutamine reprogramming. Results show that 4 mM media concentration of glutamine, compared with 2 mM, reduced viability only in metastatic cells, and that this decrease in viability was accompanied by increased incorporation of glutamine-derived carbon into the tricarboxylic acid (TCA) cycle. While increased glutamine metabolism in metastatic cells occurred in tandem with a decrease in the reduced/oxidized glutathione ratio, treatment with the antioxidant molecule N-acetylcysteine did not rescue cell viability. However, the viability of metastatic cells was more sensitive to ammonium chloride treatment compared with nonmetastatic cells, suggesting a role of metabolic reprogramming in averting nitrogen cytotoxicity in nonmetastatic cells. Overall, these results demonstrate the ability of nonmetastatic cancer cells to reprogram glutamine metabolism and that this ability may be lost in metastatic cells.
Details
- Title: Subtitle
- Increased Ammonium Toxicity in Response to Exogenous Glutamine in Metastatic Breast Cancer Cells
- Creators
- Violet A Kiesel - Purdue University West LafayetteMadeline P Sheeley - Purdue University West LafayetteShawn S Donkin - Purdue University West LafayetteMichael K Wendt - Purdue University West LafayetteStephen D Hursting - University of North Carolina at Chapel HillDorothy Teegarden - Purdue University West Lafayette
- Resource Type
- Journal article
- Publication Details
- Metabolites, Vol.12(5), p.469
- DOI
- 10.3390/metabo12050469
- PMID
- 35629973
- PMCID
- PMC9145280
- NLM abbreviation
- Metabolites
- ISSN
- 2218-1989
- eISSN
- 2218-1989
- Grant note
- TR000006 / Indiana Clinical and Translation Science Institute R01CA232589, R35CA197627, R01CA207751, R21AA026675 / NIH HHS R01 CA232589 / NCI NIH HHS RSG-CSM130259 / American Cancer Society
- Language
- English
- Date published
- 05/23/2022
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984459630902771
Metrics
8 Record Views